Dr. Philip Lazarus's lab focuses on understanding how tobacco-related chemicals contribute to lung cancer, particularly through the metabolism of specific compounds called nitrosamines. They aim to identify genetic and phenotypic markers that can help predict lung cancer risk in smokers, using diverse cohort studies. This research could lead to new prevention strategies for lung cancer, particularly for high-risk populations.